US Patent 10996228 Biomarkers for assessment of preeclampsia
Patent 10996228 was granted and assigned to DiabetOmics on May, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10996228 Biomarkers for assessment of preeclampsia
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.